Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
36.33
0.31 (0.86%)
At close: Aug 15, 2025, 11:28 AM
0.86% (1D)
| Bid | 36.31 |
| Market Cap | 6.79B |
| Revenue (ttm) | 261.59M |
| Net Income (ttm) | -777.69M |
| EPS (ttm) | -4.52 |
| PE Ratio (ttm) | -8.04 |
| Forward PE | -7 |
| Analyst | Buy |
| Ask | 36.4 |
| Volume | 245,430 |
| Avg. Volume (20D) | 2,250,527 |
| Open | 36.84 |
| Previous Close | 36.02 |
| Day's Range | 35.82 - 36.84 |
| 52-Week Range | 29.17 - 62.40 |
| Beta | 1.16 |
About RVMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RVMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RVMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Revolution Medicines Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.71%
Revolution Medicines shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
+11.29%
Revolution Medicines shares are trading higher after Oppenheimer raised its price target on the stock from $70 to $75.
1 week ago · seekingalpha.com
Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call TranscriptRevolution Medicines, Inc. (NASDAQ:RVMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Anthony Mancini - Chief Global Commercialization Officer Jack Anders - Chief F...
